Johan Liwing most recently served as CEO of Lipigon Pharmaceuticals, which has lipid‑related development programs, and before that he was CEO of XNK Therapeutics, a company focused on autologous NK‑cell therapies. Prior to that, he held several roles within what was then Janssen (now Johnson & Johnson Innovative Medicine).
CAR‑T developer Elicera appoints new CEO
Swedish CAR‑T developer Elicera has appointed Johan Liwing as its new CEO, succeeding Jamal El‑Mosleh, who is stepping down.
Advertisement
BREAKING